Cargando...
Thalidomide ameliorates portal hypertension via nitric oxide synthase independent reduced systolic blood pressure
AIM: Portal hypertension is a common complication of liver cirrhosis and significantly increases mortality and morbidity. Previous reports have suggested that the compound thalidomide attenuates portal hypertension (PHT). However, the mechanism for this action is not fully elucidated. One hypothesis...
Guardado en:
| Publicado en: | World J Gastroenterol |
|---|---|
| Autores principales: | , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Baishideng Publishing Group Inc
2015
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4394073/ https://ncbi.nlm.nih.gov/pubmed/25892862 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v21.i14.4126 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|